|
US20020032160A1
(en)
*
|
1995-02-24 |
2002-03-14 |
Nyce Jonathan W. |
Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
|
|
US5660835A
(en)
*
|
1995-02-24 |
1997-08-26 |
East Carolina University |
Method of treating adenosine depletion
|
|
US6653297B1
(en)
*
|
1997-07-03 |
2003-11-25 |
Medical College Of Hampton Roads |
Control of selective estrogen receptor modulators
|
|
EP0943333A1
(de)
*
|
1998-03-18 |
1999-09-22 |
S.W. Patentverwertungs GmbH |
Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
|
|
GB9923076D0
(en)
|
1999-09-29 |
1999-12-01 |
Phytopharm Plc |
Sapogenin derivatives and their use
|
|
WO2000009070A2
(en)
*
|
1998-08-13 |
2000-02-24 |
Hadasit Medical Research Services And Development Company Ltd. |
Inhibition of pathogenic processes related to tissue trauma
|
|
IL152081A0
(en)
*
|
2000-04-12 |
2003-05-29 |
Novartis Ag |
Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists
|
|
AU6800101A
(en)
*
|
2000-07-05 |
2002-01-14 |
Astrazeneca Ab |
Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition
|
|
AU2001271162A1
(en)
*
|
2000-07-05 |
2002-01-14 |
Astrazeneca Ab |
Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition
|
|
US20030158160A1
(en)
*
|
2000-07-05 |
2003-08-21 |
Barrington Furr |
Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
|
|
JP2004269356A
(ja)
*
|
2000-12-27 |
2004-09-30 |
Ajinomoto Co Inc |
創傷部癒着防止剤
|
|
US6559177B2
(en)
|
2001-04-19 |
2003-05-06 |
Wyeth |
5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
|
|
AU2002303427A1
(en)
|
2001-04-24 |
2002-11-05 |
East Carolina University |
Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease
|
|
US20050070487A1
(en)
*
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
US6589980B2
(en)
|
2001-05-17 |
2003-07-08 |
Wyeth |
Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
|
|
ATE432689T1
(de)
|
2002-03-04 |
2009-06-15 |
Ipsen Pharma |
Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
|
|
JP2005530820A
(ja)
*
|
2002-06-17 |
2005-10-13 |
エピジェネシス ファーマシューティカルズ リミティド ライアビリティー カンパニー |
二水和デヒドロエピアンドロステロン及びその組成物を用いた喘息又は慢性閉塞性肺疾患の治療方法
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
EP1621199B8
(en)
*
|
2003-04-18 |
2011-01-19 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
ES2282767T3
(es)
*
|
2003-07-29 |
2007-10-16 |
Acme S.R.L. |
Uso se estanozolol para la preparacion de farmacos antiinflamatorios yantidegenerativos.
|
|
US20090285900A1
(en)
*
|
2003-07-31 |
2009-11-19 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090263381A1
(en)
*
|
2003-07-31 |
2009-10-22 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026883A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090285899A1
(en)
*
|
2003-07-31 |
2009-11-19 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026879A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026884A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026848A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050085430A1
(en)
*
|
2003-07-31 |
2005-04-21 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050101545A1
(en)
*
|
2003-07-31 |
2005-05-12 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026880A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026882A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090274676A1
(en)
*
|
2003-07-31 |
2009-11-05 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026881A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050043282A1
(en)
*
|
2003-07-31 |
2005-02-24 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050113318A1
(en)
*
|
2003-07-31 |
2005-05-26 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20110209699A1
(en)
*
|
2003-07-31 |
2011-09-01 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050038004A1
(en)
*
|
2003-07-31 |
2005-02-17 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
EP2803357B1
(en)
*
|
2004-06-25 |
2020-11-18 |
The Johns-Hopkins University |
Angiogenesis inhibitors
|
|
US7206718B2
(en)
*
|
2004-09-21 |
2007-04-17 |
Diapedic, L.L.C. |
Method for design and manufacture of insoles
|
|
US20060189909A1
(en)
*
|
2005-02-24 |
2006-08-24 |
Hurley Timothy B |
Load relieving wound dressing
|
|
US20070009470A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Kin Jung |
Topical/on-the-skin estrogen cream, lotion, ointment, hair tonic, shampoo and wound healing powder
|
|
ITMI20051516A1
(it)
|
2005-08-02 |
2007-02-03 |
Prime Europ Therapeuticals |
Derivati 17 alfa-sostituti dell'estradiolo ad attivita' cicatrizzante
|
|
US20070163147A1
(en)
*
|
2005-09-21 |
2007-07-19 |
Cavanagh Peter R |
Method for Design and Manufacture of Insoles
|
|
JP5960944B2
(ja)
|
2006-11-15 |
2016-08-02 |
コーダ セラピューティクス， インコーポレイテッド |
創傷治癒のための改善された方法および組成物
|
|
US20080132475A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Charles Gerald Connor |
Treatment for dry eye
|
|
GB0625962D0
(en)
*
|
2006-12-23 |
2007-02-07 |
Renovo Ltd |
Medicaments and methods for wound healing
|
|
WO2008078073A1
(en)
*
|
2006-12-23 |
2008-07-03 |
Renovo Limited |
Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing
|
|
WO2008078074A1
(en)
*
|
2006-12-23 |
2008-07-03 |
Renovo Limited |
Promotion of wound contraction with a compound that promotes oestrogenic activity
|
|
US20100016264A1
(en)
*
|
2007-12-05 |
2010-01-21 |
Connor Charles G |
Treatment for dry eye using testosterone and progestagen
|
|
GB0724231D0
(en)
*
|
2007-12-12 |
2008-01-30 |
Renono Ltd |
Methods for inhibiting scarring
|
|
EP2238250B1
(en)
*
|
2007-12-21 |
2017-07-19 |
CoDa Therapeutics, Inc. |
Use of anti-connexin 43 polynucleotides, peptides or antibodies for the treatment of orthopedic conditions
|
|
WO2009085272A2
(en)
|
2007-12-21 |
2009-07-09 |
Coda Therapeutics, Inc. |
Improved medical devices
|
|
US10279007B2
(en)
|
2010-11-15 |
2019-05-07 |
Oxygenetix Institute, Inc. |
Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
|
|
CN104080458B
(zh)
*
|
2011-09-13 |
2020-06-02 |
布莱阿姆青年大学 |
用于组织创伤的愈合的产品
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
EP2782584B1
(en)
|
2011-11-23 |
2021-06-09 |
TherapeuticsMD, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
KR101873773B1
(ko)
|
2012-05-11 |
2018-08-02 |
주식회사 젬백스앤카엘 |
류마티즘 관절염 예방 또는 치료 조성물
|
|
KR20210025132A
(ko)
|
2012-05-11 |
2021-03-08 |
주식회사 젬백스앤카엘 |
항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
WO2014010971A1
(ko)
|
2012-07-11 |
2014-01-16 |
주식회사 카엘젬백스 |
세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
RU2677277C2
(ru)
|
2013-06-07 |
2019-01-16 |
Джемвакс Энд Каэл Ко., Лтд. |
Биологические маркеры, которые могут быть использованы в иммунотерапии рака
|
|
JP6495899B2
(ja)
|
2013-06-21 |
2019-04-03 |
ジェムバックス アンド カエル カンパニー，リミティド |
ホルモン分泌調節剤、及びそれを含む組成物
|
|
JP6553605B2
(ja)
|
2013-11-22 |
2019-07-31 |
ジェムバックス アンド カエル カンパニー，リミティド |
血管新生抑制活性を有するペプチド、及びそれを含む組成物
|
|
ES2809251T3
(es)
|
2013-12-17 |
2021-03-03 |
Gemvax & Kael Co Ltd |
Composición para tratar cáncer de próstata
|
|
WO2015156649A1
(ko)
|
2014-04-11 |
2015-10-15 |
주식회사 젬백스앤카엘 |
섬유증 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
|
US10662223B2
(en)
|
2014-04-30 |
2020-05-26 |
Gemvax & Kael Co., Ltd. |
Composition for organ, tissue, or cell transplantation, kit, and transplantation method
|
|
AU2015264003A1
(en)
|
2014-05-22 |
2016-11-17 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
CA2958879A1
(en)
|
2014-08-22 |
2016-02-25 |
Auckland Uniservices Limited |
Channel modulators
|
|
KR102413243B1
(ko)
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
|
ES2799511T3
(es)
|
2015-02-27 |
2020-12-18 |
Gemvax & Kael Co Ltd |
Péptido para prevenir la pérdida de audición, y composición que lo comprende
|
|
EP3318265B1
(en)
|
2015-07-02 |
2021-08-18 |
Gemvax & Kael Co., Ltd. |
Peptide having anti-viral effect and composition containing same
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
|
KR20180123512A
(ko)
|
2016-04-07 |
2018-11-16 |
주식회사 젬백스앤카엘 |
텔로머라제 활성 증가 및 텔로미어 연장 효능을 가지는 펩티드 및 이를 포함하는 조성물
|
|
WO2020160225A1
(en)
*
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
|
KR102842907B1
(ko)
*
|
2019-09-27 |
2025-08-07 |
(주)아모레퍼시픽 |
신규 진세노사이드를 포함하는 갱년기 증상의 예방 또는 개선용 조성물
|